Early recognition and management of Lemierre's syndrome with extensive central venous thrombosis: a case from the emergency department
Abstract
INTRODUCTION: Lemierre’s syndrome is a rare but potentially life-threatening condition. It typically develops as a complication of oropharyngeal infections, leading to bacteremia, septic thrombophlebitis of the internal jugular vein (IJV), and metastatic septic emboli. According to the literature, Lemierre’s syndrome predominantly affects previously healthy young adults, with a mean age at presentation of around 20 years, although it has also been reported in school-aged children. Diagnosis is frequently delayed or missed, as the initial manifestations—such as sore throat or neck pain—closely resemble benign viral infections. Emergency physicians therefore play a critical role in recognizing early warning signs and initiating prompt, lifesaving management. This report describes an atypical presentation of Lemierre’s syndrome in a middle-aged (43-year-old) woman who exhibited minimal systemic toxicity despite extensive central venous involvement.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.